Diseases, Conditions, Syndromes

Potential Zika virus risk estimated for 50 US cities

Key factors that can combine to produce a Zika virus outbreak are expected to be present in a number of U.S. cities during peak summer months, new research shows.

Diseases, Conditions, Syndromes

Ireland's third virus lockdown set to last to April

Ireland's virus lockdown is set to be extended until April, Prime Minister Micheal Martin said Thursday, as the country battles to get infection rates and deaths down.

Diseases, Conditions, Syndromes

Study puts troubling traits of H7N9 avian flu virus on display

The emerging H7N9 avian influenza virus responsible for at least 37 deaths in China has qualities that could potentially spark a global outbreak of flu, according to a new study published today (July 10, 2013) in the journal ...

Diseases, Conditions, Syndromes

Do masks offer protection from new virus? It depends

People around the world are buying up protective face masks in hopes of keeping the new virus from China at bay. Some companies have required them for employees. Schools in South Korea have told parents to equip their children ...

Medical research

New hope for hep C vaccine

Hopes for an effective vaccine and treatment against the potentially fatal hepatitis C infection have received a major boost following the discovery of two 'Achilles' heels' within the virus.

Addiction

Coffee drinking improves hepatitis C treatment response

Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association ...

Diseases, Conditions, Syndromes

Rapid, easy Zika test developed

A new fast, easy and cheap "dipstick" test for the Zika and dengue viruses could revolutionize public health response to dangerous tropical germs, a new study reports.

Diseases, Conditions, Syndromes

New therapy for flu may help in fight against COVID-19

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

page 9 from 40